news

Sept 16 2014
Synthetic Biologics' Statin-Class Candidate for Constipation-Predominant Irritable Bowel Syndrome Detailed at Company's Investor Day

Sept 16 2014
Omni Bio to Present at 7th Annual BioPharm America Conference

Sept 15 2014
EnGeneIC Named a Recipient of the Cancer Institute NSW Premier's Award for Excellence in Translational Cancer Research

 

events

 

spotlight